Collaboration in more than 46 countries.

You are leaving the country website to access another site in the group. Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you enter may not be suitable for use in your country.

NORTH AMERICA

Canada

United States

LATIN AMERICA

Argentina

Brazil

Mexico

Perú

GLOBAL

CEVA Global

EMEA (REGIONAL)

Denmark

Egypt

France

Germany

Hungary

Italy

Netherlands

Poland

Portugal

Romania

South Africa

Spain

Sweden

Tunisia

Turkey

Ukraine

United Kingdom

ASIA PACIFIC

Asia Pacific (Regional)

CHINA

India

Indonesia

Japan

Kore

Malaysia

Philippines

20th December 2024

Ceva has added a 50ml vial presentation to its synthetic prostaglandin (cloprostenol) Cevaprost, for use in cattle fertility management and synchronisation.

Commenting on the new presentation, Craig Wright, Ruminant Business Unit Director for Ceva UK says, “Based on customer feedback and demand, we are pleased to introduce a larger vial option to our repro range of prostaglandins. This addition enhances the product’s usability in the field, where a larger vial format offers greater convenience and ease of use”.

SUMMARY 

  • Licensed for use in cattle
  • Active Ingredient Cloprostenol 0.250 mg/ml (as 0.263 mg/ml cloprostenol sodium)
  • Available in 10 x 20ml vials or 1 x 50ml presentations
  • Legal Category: POM-V

 

Equivalent licence: The licensed indications are equivalent to those of the leading racemic and single isomer cloprostenols available on the UK market.

Indications for use:

  • Silent heat
  • Ovarian luteal cysts
  • Termination of pregnancy
  • Induction of parturition
  • Removal of mummified foetus
  • Chronic endometritis (pyometra)
  • Synchronisation of oestrus (within 2 to 5 days) in groups of cyclic females treated simultaneously

 

Vets: for further information and orders please contact your Ceva Territory Manager

Farmers: please speak to your farm vet for further information

Click link to find out more about Cevaprost from our website

Cevaprost SPC:  SPC_1922213.PDF

 

Cevaprost® cloprostenol 250 μg/ml solution for injection contains cloprostenol 0.250 mg/ml (as 0.263 mg/ml cloprostenol sodium).  Legal Category for all products: UK POM-V

Prescription decisions are for the person prescribing the prescription alone. Further information is available from the product SPC, data sheet or pack insert.  Use medicines responsibly (www.noah.co.uk/responsible)

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.